Tenax Therapeutics (TENX) Fully Funded Through 2027 With $105.5M Cash
Tenax Therapeutics Inc. (NASDAQ:TENX) is a late-stage clinical biopharmaceutical company committed to transforming the treatment landscape for patients…
Browsing Tag